Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Propranolol Adjuvant Treatment of Bladder Cancer: a Randomized Phase II Clinical Trial

NCT04493489 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT04493489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04493489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Propranolol Adjuvant Treatment of Bladder Cancer: a Randomized Phase II Clinical Trial
Lead sponsor
Central South University
Phase
Phase 2
Overall status
Unknown status
Start date
September 6, 2020
Completion date
September 6, 2024
Enrollment
242 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer